Cardiovascular benefits of air purifier in patients with stable coronary artery disease: A randomized single-blind crossover study.

ABSTRACT:

Background

Exposure to PM_2.5 will accelerate the progression of cardiovascular diseases. Air purifier can reduce the PM_2.5 exposure and theoretically alleviate the influence of PM_2.5 on patients with stable coronary artery disease (SCAD). However, few studies of the protective effect showed significant results because the interferent effects of routine medication had not been taken into account. In order to explore the actual effect on patients with SCAD, we conducted a randomized single-blind crossover air purifier intervention trial.

Method

Levels of PM_2.5 exposure during intervention and cardiovascular indicators (inflammation, coagulation, plaque stability, and blood lipids) after intervention were detected, meanwhile the infor

SUBMITTER: Liu Z 

PROVIDER: S-EPMC9868303 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature